The Relative Strength (RS) Rating for ACM Research Cl A jumped into a new percentile Thursday, as it got a lift from 69 to 72.
IBD's unique RS Rating measures technical performance by showing how a stock's price action over the last 52 weeks compares to that of the other stocks in our database.
Decades of market research reveals that the stocks that go on to make the biggest gains typically have an 80 or higher RS Rating as they launch their largest price moves. See if ACM Research Cl A can continue to show renewed price strength and clear that threshold.
Can You Really Time The Stock Market?
Now is not an ideal time to jump in since it isn't near a proper buy zone, but see if the stock manages to offer and clear a proper buy point.
The company reported 15% EPS growth in the latest quarterly report. Sales increased 40%. Keep an eye out for the company's next round of numbers on or around Nov. 7.
ACM Research Cl A holds the No. 3 rank among its peers in the Electronics-Semiconductor Equipment industry group. Nova is the top-ranked stock within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
